下一代肿瘤不可知靶点即将出现
Next-generation tumor-agnostic targets on the horizon.
肿瘤不可知药物开发将肿瘤学重新聚焦于共享的分子依赖性而非组织来源,从而能够针对跨肿瘤的罕见可操作驱动因素进行高效开发。
英文原题:Advances in cell therapy for orthopedic diseases: bridging immune modulation and regeneration.
骨科疾病因其高患病率、致残性影响以及有限的治疗选择,给公共卫生带来了重大挑战。
骨科疾病因其高患病率、致残性影响以及有限的治疗选择,给公共卫生带来了重大挑战。此外,骨科肿瘤,如骨肉瘤、软骨肉瘤和尤文肉瘤,进一步增加了治疗格局的复杂性。当前的治疗方法,包括药物治疗和关节置换,只能缓解症状,却无法促进真正的组织再生。基于细胞的疗法已在癌症和其他疾病中展现出成功的临床结果,已成为修复受损组织和恢复骨科疾病及肿瘤功能的一种有前景的解决方案。本综述讨论了细胞疗法在骨科疾病中的进展和潜在应用,特别关注骨关节炎、骨折、软骨退变以及骨科肿瘤的治疗。我们探讨了间充质基质细胞(MSCs)、软骨细胞移植、工程化免疫细胞和诱导多能干细胞通过调节免疫反应和应对炎症来增强组织再生的潜力。最终,将前沿细胞疗法、免疫调节和分子靶向策略相结合,可能彻底改变骨科疾病和肿瘤的治疗,为寻求长期解决方案以应对致残性疾病的患者带来希望。
Orthopedic diseases pose significant challenges to public health due to their high prevalence, debilitating effects, and limited treatment options. Additionally, orthopedic tumors, such as osteosarcoma, chondrosarcoma, and Ewing sarcoma, further complicate the treatment landscape. Current therapies, including pharmacological treatments and joint replacement, address symptoms but fail to promote true tissue regeneration. Cell-based therapies, which have shown successful clinical results in cancers and other diseases, have emerged as a promising solution to repair damaged tissues and restore function in orthopedic diseases and tumors. This review discusses the advances and potential application of cell therapy for orthopedic diseases, with a particular focus on osteoarthritis, bone fractures, cartilage degeneration, and the treatment of orthopedic tumors. We explore the potential of mesenchymal stromal cells (MSCs), chondrocyte transplantation, engineered immune cells and induced pluripotent stem cells to enhance tissue regeneration by modulating the immune response and addressing inflammation. Ultimately, the integration of cutting-edge cell therapy, immune modulation, and molecular targeting strategies could revolutionize the treatment of orthopedic diseases and tumors, providing hope for patients seeking long-term solutions to debilitating conditions.
MEMBER ACCOUNT
登录成功会直接打开下一页。